Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid TumorsMasayuki Takeda, Kazuto Nishio, Satomi Watanabe et al.|The Oncologist|2020Cited by 95
594P The efficacy of anti-EGFR therapy for RAS mutant metastatic colorectal cancer (mCRC) patients with RAS mutation negative in circulating-tumor DNA (ctDNA) after 1st- or 2nd-line chemotherapyN. Izawa, Yu Sunakawa, Toshihiro Kudo et al.|Annals of Oncology|2023Cited by 1